A 35-year-old woman is evaluated for weakness in the right foot and left wrist with paresthesia in the right leg, right foot, left forearm, and left hand. She also reports facial erythema and joint stiffness. She has a 6-year history of systemic lupus erythematosus (SLE). Medications are hydroxychloroquine, prednisone, vitamin D, and calcium.

On physical examination, vital signs are normal. There is a new malar rash. Swelling of the second through fourth metacarpophalangeal joints of the hands is present. There is dorsiflexion weakness of the right ankle and a left wrist drop. Reflexes are normal. The remainder of the examination is normal.

Laboratory studies indicate that her SLE appears to be active with an elevation of erythrocyte sedimentation rate compared with baseline, leukopenia, and anemia typical of her previous SLE flares.

Which of the following is the most appropriate next step in management?